Copyright Reports & Markets. All rights reserved.

Post-pandemic Era-Global Chronic Urticaria Or Hives Drug Market 2016-2027, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin

Request for Sample of this report
Buy now

Table of Contents

    Global Chronic Urticaria Or Hives Drug Market 2016-2027, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin

      1 Market Scope

      • 1.1 Product Details and Introduction
        • 1.1.1 GDC-0853 -Product Introduction and Major Manufacturers
        • 1.1.2 GSK-2646264 -Product Introduction and Major Manufacturers
        • 1.1.3 BF-Derm-1 -Product Introduction and Major Manufacturers
        • 1.1.4 Bilastine -Product Introduction and Major Manufacturers
        • 1.1.5 Others -Product Introduction and Major Manufacturers
      • 1.2 Market Snapshot
        • 1.2.1 Major Companies Overview
        • 1.2.2 Market Concentration
        • 1.2.3 Six-Year Compound Annual Growth Rate (CAGR)

      2 Regional Market Analysis

      • 2.1 China Chronic Urticaria Or Hives Drug Status and Prospect (2016-2027)
        • 2.1.1 China Chronic Urticaria Or Hives Drug Market Size and Growth Rate (2016-2027)
        • 2.1.2 China Chronic Urticaria Or Hives Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
      • 2.2 EU Chronic Urticaria Or Hives Drug Status and Prospect (2016-2027)
        • 2.2.1 EU Chronic Urticaria Or Hives Drug Market Size and Growth Rate (2016-2027)
        • 2.2.2 EU Chronic Urticaria Or Hives Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
      • 2.3 USA Chronic Urticaria Or Hives Drug Status and Prospect (2016-2027)
        • 2.3.1 USA Chronic Urticaria Or Hives Drug Market Size and Growth Rate (2016-2027)
        • 2.3.2 USA Chronic Urticaria Or Hives Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
      • 2.4 Japan Chronic Urticaria Or Hives Drug Status and Prospect (2016-2027)
        • 2.4.1 Japan Chronic Urticaria Or Hives Drug Market Size and Growth Rate (2016-2027)
        • 2.4.2 Japan Chronic Urticaria Or Hives Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
      • 2.5 India Chronic Urticaria Or Hives Drug Status and Prospect (2016-2027)
        • 2.5.1 India Chronic Urticaria Or Hives Drug Market Size and Growth Rate (2016-2027)
        • 2.5.2 India Chronic Urticaria Or Hives Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
      • 2.6 Southeast Asia Chronic Urticaria Or Hives Drug Status and Prospect (2016-2027)
        • 2.6.1 Southeast Asia Chronic Urticaria Or Hives Drug Market Size and Growth Rate (2016-2027)
        • 2.6.2 Southeast Asia Chronic Urticaria Or Hives Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
      • 2.7 South America Chronic Urticaria Or Hives Drug Status and Prospect (2016-2027)
        • 2.7.1 South America Chronic Urticaria Or Hives Drug Market Size and Growth Rate (2016-2027)
        • 2.7.2 South America Chronic Urticaria Or Hives Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
      • 2.8 Chronic Urticaria Or Hives Drug Status and Prospect (2016-2027)
        • 2.8.1 Chronic Urticaria Or Hives Drug Market Size and Growth Rate (2016-2027)
        • 2.8.2 Chronic Urticaria Or Hives Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)

      3 Global Chronic Urticaria Or Hives Drug Market Assessment by Segment

      • 3.1 Global Chronic Urticaria Or Hives Drug Capacity and Growth Rate
      • 3.2 Global Chronic Urticaria Or Hives Drug Sales by Type
      • 3.3 Global Chronic Urticaria Or Hives Drug Sales Revenue by Type
      • 3.4 Global Chronic Urticaria Or Hives Drug Consumption by Application

      4 Global Chronic Urticaria Or Hives Drug Market Assessment by Regions

      • 4.1 Global Chronic Urticaria Or Hives Drug Production Analysis and Forecast by Regions (2016-2027)
      • 4.2 Global Chronic Urticaria Or Hives Drug Sales Analysis and Forecast by Regions (2016-2027)
      • 4.3 Global Chronic Urticaria Or Hives Drug Sales Revenue Analysis and Forecast by Regions (2016-2027)

      5 Value Chain (Impact of COVID-19)

      • 5.1 Chronic Urticaria Or Hives Drug Value Chain Analysis
        • 5.1.1 Upstream
        • 5.1.2 Downstream
      • 5.2 COVID-19 Impact on Chronic Urticaria Or Hives Drug Industry
        • 5.2.1 Industrial Policy Issued Under the Epidemic Situation
      • 5.3 Cost-Under the Epidemic Situation
        • 5.3.1 Cost of Raw Material
      • 5.4 Channel Analysis
        • 5.4.1 Distribution Channel-Under the Epidemic Situation
        • 5.4.2 Distributors

      6 Competitive Landscape

      • 6.1 Global Chronic Urticaria Or Hives Drug Capacity Market Share of Manufacturers (2019-2020)
      • 6.2 Global Chronic Urticaria Or Hives Drug Sales Market Share of Manufacturers (2019-2020)
      • 6.3 Global Chronic Urticaria Or Hives Drug Sales Revenue Market Share of Manufacturers (2019-2020)

      7 Chronic Urticaria Or Hives Drug Competitive Analysis

      • 7.1 AstraZeneca Plc
        • 7.1.1 AstraZeneca Plc Company Profiles
        • 7.1.2 AstraZeneca Plc Product Introduction
        • 7.1.3 AstraZeneca Plc Chronic Urticaria Or Hives Drug Production, Revenue (2015-2020)
        • 7.1.4 SWOT Analysis
      • 7.2 Biofrontera AG
        • 7.2.1 Biofrontera AG Company Profiles
        • 7.2.2 Biofrontera AG Product Introduction
        • 7.2.3 Biofrontera AG Chronic Urticaria Or Hives Drug Production, Revenue (2015-2020)
        • 7.2.4 SWOT Analysis
      • 7.3 ELORAC, Inc.
        • 7.3.1 ELORAC, Inc. Company Profiles
        • 7.3.2 ELORAC, Inc. Product Introduction
        • 7.3.3 ELORAC, Inc. Chronic Urticaria Or Hives Drug Production, Revenue (2015-2020)
        • 7.3.4 SWOT Analysis
      • 7.4 Faes Farma, SA
        • 7.4.1 Faes Farma, SA Company Profiles
        • 7.4.2 Faes Farma, SA Product Introduction
        • 7.4.3 Faes Farma, SA Chronic Urticaria Or Hives Drug Production, Revenue (2015-2020)
        • 7.4.4 SWOT Analysis
      • 7.5 Genentech, Inc.
        • 7.5.1 Genentech, Inc. Company Profiles
        • 7.5.2 Genentech, Inc. Product Introduction
        • 7.5.3 Genentech, Inc. Chronic Urticaria Or Hives Drug Production, Revenue (2015-2020)
        • 7.5.4 SWOT Analysis
      • 7.6 GlaxoSmithKline Plc
        • 7.6.1 GlaxoSmithKline Plc Company Profiles
        • 7.6.2 GlaxoSmithKline Plc Product Introduction
        • 7.6.3 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Production, Revenue (2015-2020)
        • 7.6.4 SWOT Analysis
      • 7.7 J Uriach Y Compania, S.A.
        • 7.7.1 J Uriach Y Compania, S.A. Company Profiles
        • 7.7.2 J Uriach Y Compania, S.A. Product Introduction
        • 7.7.3 J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Production, Revenue (2015-2020)
        • 7.7.4 SWOT Analysis
      • 7.8 Mabtech Limited
        • 7.8.1 Mabtech Limited Company Profiles
        • 7.8.2 Mabtech Limited Product Introduction
        • 7.8.3 Mabtech Limited Chronic Urticaria Or Hives Drug Production, Revenue (2015-2020)
        • 7.8.4 SWOT Analysis
      • 7.9 Merck & Co., Inc.
        • 7.9.1 Merck & Co., Inc. Company Profiles
        • 7.9.2 Merck & Co., Inc. Product Introduction
        • 7.9.3 Merck & Co., Inc. Chronic Urticaria Or Hives Drug Production, Revenue (2015-2020)
        • 7.9.4 SWOT Analysis
      • 7.10 Mycenax Biotech Inc.
        • 7.10.1 Mycenax Biotech Inc. Company Profiles
        • 7.10.2 Mycenax Biotech Inc. Product Introduction
        • 7.10.3 Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Production, Revenue (2015-2020)
        • 7.10.4 SWOT Analysis
      • 7.11 Novartis AG
      • 7.12 Panacea Biotec Limited

      8 Conclusion

      Summary

      World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war.

      Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing global slowdown, which got aggravated due to the current Covid-19 crisis. The latter resulted in large scale disruptions in supply chains and demand resulting in cancellation of orders.

      XYZResearch’s analysis shows that as China started reopening its economy, world exports initially recovered across the board. But estimates of the expected recovery in 2021 are uncertain, with outcomes depending largely on the duration of the outbreak and the effectiveness of the policy responses.

      This research report indicated that the global Chronic Urticaria Or Hives Drug market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. In terms of the export, China occupied more than XX % export market share in 2019, India occupied XX %. XXX is the second largest region around the world, it occupied about XX % export market share in 2019. In terms of the Local Capacity, XXX is the largest region around the world, it occupied about XX % export market share in 2019.

      Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Chronic Urticaria Or Hives Drug Market by XYZResearch Include
      China
      EU
      North America
      Japan
      India
      Southeast Asia
      South America
      Middle East and Africa
      Competitive Analysis; Who are the Major Players in Chronic Urticaria Or Hives Drug Market?
      AstraZeneca Plc
      Biofrontera AG
      ELORAC, Inc.
      Faes Farma, SA
      Genentech, Inc.
      GlaxoSmithKline Plc
      J Uriach Y Compania, S.A.
      Mabtech Limited
      Merck & Co., Inc.
      Mycenax Biotech Inc.
      Novartis AG
      Panacea Biotec Limited
      ...
      Major Type of Chronic Urticaria Or Hives Drug Covered in XYZResearch report:
      GDC-0853
      GSK-2646264
      BF-Derm-1
      Bilastine
      Others
      Application Segments Covered in XYZResearch Market
      Clinic
      Hospital
      Others

      For any other requirements, please feel free to contact us and we will provide you customized report.
      Buy now